Framework demonstrates enhanced risk prediction for gastric cancer using transfer learning from multiple gastrointestinal cancers.
Background: Timely identification of individuals at elevated risk for gastric cancer (GC) within routine care could enable earlier endoscopy and referral. We posit that cancers within the gastrointestinal/hepatopancreatobiliary spectrum share signals that can be leveraged via transfer learning on electronic health records (EHRs) variables. Methods: We developed a cross-cancer transfer learning framework (TransferGC) on structured EHR data from the MIMIC-IV database, including 508 GC cases in the target cohort, that pretrains on non-gastric gastrointestinal/hepatopancreatobiliary cancers (colorectal, esophageal, liver, pancreatic) and then adapts to GC using only structured variables. We compared transfer variants against strong non-transfer baselines (logistic regression, XGBoost, architecturally matched multilayer perceptron), with area under the receiver operating characteristic curve (AUROC) and average precision (AP) as primary endpoints and F1 and sensitivity/specificity as secondary endpoints. Results: In the full-label setting, Transfer achieved AUROC 0.854 and AP 0.600, outperforming logistic regression (LR), extreme gradient boosting (XGB) and improving over the scratch multilayer perceptron (MLP) in AUROC (+0.024) and F1 (+0.027), while AP was essentially tied (Transfer 0.600 vs. MLP 0.603). As GC labels were reduced, Transfer maintained the strongest overall performance. Conclusions: Cross-cancer transfer on structured EHR data suggests a sample-efficient route to GC risk modeling under label scarcity. However, because all models were developed and evaluated using a single-center inpatient dataset, external validation on multi-center and outpatient cohorts will be essential to establish generalizability before deployment. If confirmed in future studies, the proposed framework could be integrated into EHR-based triage and clinical decision support workflows to flag patients at elevated GC risk for timely endoscopy and specialist referral.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: